Artificial intelligence-enabled technology tools are capable of dissecting large quantities of data faster than ever before and in some cases, in real time. However, the increasingly widespread use of AI challenges regulators to balance the benefits of innovation while protecting patient safety, health and privacy rights. An Intellectual Property & Technology Law Journal article on the future of AI in life sciences provides a cross-border analysis of the evolving regulatory landscape in the U.S., Europe and China that seeks to respond to technology advances that may revolutionize all facets of research and development and health care delivery. You can read the full Intellectual Property & Technology Law Journal article on this analysis here. We will continue to monitor these regulatory and public policy developments. Subscribe to RopesDataphiles.com for updates.
A Cross-Border Look at the Future of Artificial Intelligence in Life Sciences
